Table 3.
Logistic Regression for Selected CVD Risk Factors Compared With Those in the Referent Group (Low Density/Low Ratio)
| Dependent Variable | High Density/High Ratio |
High Density/Low Ratio |
Low Density/High Ratio |
|||
|---|---|---|---|---|---|---|
| OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | |
| Women | ||||||
| Low HDL | ||||||
| MV | 1.6 (1.1 to 2.2) | .01 | 0.6 (0.4 to 0.9) | .006 | 1.7 (1.2 to 2.3) | .003 |
| MV + SAT | 2.4 (1.7 to 3.6) | <.0001 | 0.9 (0.6 to 1.4) | .70 | 2.0 (1.4 to 2.8) | <.0001 |
| High triglycerides | ||||||
| MV | 1.5 (1.1 to 2.1) | .02 | 0.4 (0.2 to 0.6) | <.0001 | 1.7 (1.2 to 2.3) | .003 |
| MV + SAT | 2.2 (1.5 to 3.5) | <.0001 | 0.5 (0.3 to 0.9) | .009 | 2.0 (1.4 to 2.8) | .0001 |
| High glucose | ||||||
| MV | 1.2 (0.8 to 1.8) | .40 | 0.3 (0.2 to 0.6) | <.0001 | 1.6 (1.1 to 2.4) | .008 |
| MV + SAT | 1.9 (1.3 to 2.9) | .003 | 0.6 (0.3 to 1.0) | .04 | 2.1 (1.4 to 3.0) | .0002 |
| Diabetes | ||||||
| MV | 6.7 (2.6 to 17.6) | .0001 | 2.4 (0.8–6.9) | .12 | 2.0 (0.7 to 5.6) | .18 |
| MV + SAT | 10.8 (4.1 to 29.0) | <.0001 | 4.2 (1.4–12.5) | .01 | 2.6 (0.9 to 7.2) | .08 |
| Hypertension | ||||||
| MV | 1.6 (1.1 to 2.4) | .009 | 0.6 (0.4 to 0.9) | .01 | 1.8 (1.3 to 2.5) | .001 |
| MV + SAT | 2.5 (1.7 to 3.7) | <.001 | 0.9 (0.6 to 1.4) | .63 | 2.1 (1.5 to 3.1) | <.0001 |
| CVD | ||||||
| MV | 3.9 (1.3 to 11.6) | .02 | 0.8 (0.2 to 3.8) | .82 | 2.9 (1.0 to 8.8) | .06 |
| MV + SAT | 3.4 (1.1 to 10.5) | .03 | 0.7 (0.2 to 3.4) | .68 | 2.8 (0.9 to 8.4) | .07 |
| Metabolic syndrome | ||||||
| MV | 1.7 (1.2 to 2.4) | .005 | 0.3 (0.2 to 0.5) | <.0001 | 2.1 (1.5 to 3.0) | <.0001 |
| MV + SAT | 4.8 (3.1 to 7.4) | <.0001 | 0.8 (0.4 to 1.3) | .30 | 3.8 (2.6 to 5.6) | <.0001 |
| Men | ||||||
| Low HDL | ||||||
| MV | 1.5 (1.1 to 2.0) | .005 | 0.4 (0.3 to 0.6) | <.0001 | 1.3 (0.9 to 1.7) | .11 |
| MV + SAT | 2.5 (1.8 to 3.5) | <.0001 | 0.6 (0.4 to 0.9) | .02 | 1.7 (1.2 to 2.4) | .001 |
| High triglycerides | ||||||
| MV | 1.2 (0.9 to 1.5) | .26 | 0.4 (0.3 to 0.6) | <.0001 | 1.5 (1.2 to 2.0) | .003 |
| MV + SAT | 1.9 (1.4 to 2.7) | <.0001 | .6 (0.4 to 0.9) | .005 | 2.0 (1.5 to 2.8) | <.0001 |
| High glucose | ||||||
| MV | 0.7 (0.5 to 0.9) | .003 | 0.5 (0.3 to 0.6) | <.0001 | 1.1 (0.8 to 1.5) | .47 |
| MV + SAT | 1.0 (0.7 to 1.4) | .98 | 0.6 (0.5 to 0.9) | .009 | 1.4 (1.0 to 1.9) | .03 |
| Diabetes | ||||||
| MV | 1.6 (0.9 to 2.6) | .09 | 1.2 (0.7 to 2.2) | .47 | 0.5 (0.2 to 1.0) | .048 |
| MV + SAT | 4.8 (2.6 to 9.2) | <.0001 | 2.6 (1.4 to 4.9) | .004 | 1.0 (0.5 to 2.0) | .91 |
| Hypertension | ||||||
| MV | 0.8 (0.6 to 1.0) | .08 | 0.4 (0.3 to 0.5) | <.0001 | 0.8 (0.6 to 1.1) | .13 |
| MV + SAT | 1.5 (1.0 to 2.1) | .03 | 0.6 (0.4 to 0.9) | .01 | 1.1 (0.8 to 1.6) | .48 |
| CVD | ||||||
| MV | 1.2 (0.7 to 2.0) | .62 | 0.9 (0.5 to 1.7) | .76 | 1.3 (0.7 to 2.3) | .41 |
| MV + SAT | 1.8 (0.9 to 3.5) | .07 | 1.2 (0.6 to 2.5) | .57 | 1.7 (0.9 to 3.1) | .11 |
| Metabolic syndrome | ||||||
| MV | 0.6 (0.4 to 0.8) | .0002 | 0.3 (0.2 to 0.4) | <.0001 | 1.0 (0.8 to 1.4) | .86 |
| MV + SAT | 2.5 (1.7 to 3.6) | <.0001 | 0.6 (0.4 to 0.9) | .02 | 2.3 (1.7 to 3.2) | <.0001 |
Estimates give differences in odds of the dependent variable in each group compared with the referent group (low SAT HU/low ratio). The multivariable (MV) model adjusts for age, current smoking status, alcohol use, physical activity, and hormone replacement therapy (models in women only). The MV + SAT model also adjusts for the absolute volume of SAT.